Summary Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes OmniPod insulin management system, an insulin infusion system for diabetic patients. OmniPod insulin management system consists of OmniPod, a disposable insulin infusion device and the Personal Diabetes Manager, a handheld wireless device. Its OmniPod is a tubeless insulin pump that has two parts and a fully-automated cannula insertion. The company’s delivery systems business collaborates with several global pharmaceutical and biotechnology companies to adapt the OmniPod technology platform for the delivery of subcutaneous drugs across various therapeutic areas. The company markets its products in the US, Europe, and Asia through direct sales and distribution partners. Insulet is headquartered in Bedford, Massachusetts, the US. Insulet Corp (PODD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.... Research Beam Model: Research Beam Product ID: 1916504 250 USD New
Insulet Corp (PODD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Insulet Corp (PODD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Company Profiles
  • Published On : July   2017
  • Pages : 31
  • Publisher : GlobalData
 
 
 
Summary

Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes OmniPod insulin management system, an insulin infusion system for diabetic patients. OmniPod insulin management system consists of OmniPod, a disposable insulin infusion device and the Personal Diabetes Manager, a handheld wireless device. Its OmniPod is a tubeless insulin pump that has two parts and a fully-automated cannula insertion. The company’s delivery systems business collaborates with several global pharmaceutical and biotechnology companies to adapt the OmniPod technology platform for the delivery of subcutaneous drugs across various therapeutic areas. The company markets its products in the US, Europe, and Asia through direct sales and distribution partners. Insulet is headquartered in Bedford, Massachusetts, the US.

Insulet Corp (PODD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Insulet Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Insulet Corp, Medical Devices Deals, 2011 to YTD 2017 9
Insulet Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Insulet Corp, Pharmaceuticals & Healthcare, Deal Details 11
Debt Offering 11
Insulet Raises Private Placement of Senior Notes for USD345 Million 11
Insulet Prices Public Offering of 2% Notes Due 2019 for USD175 Million 12
Asset Transactions 13
Sinoxa Pharma Acquires Patent Rights To Omnipod Patch-Pump Technology From Insulet 13
Acquisition 14
Insulet Acquires Neighborhood Diabetes 14
Insulet Corp - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
May 08, 2017: Insulet Reports First Quarter 2017 Financial Results 19
Feb 27, 2017: Insulet Reports Fourth Quarter and Full Year 2016 Financial Results 20
Aug 03, 2016: Insulet Reports Second Quarter 2016 Financial Results 22
May 03, 2016: Insulet Reaffirms Second Quarter and Full Year 2016 Guidance 23
Apr 28, 2016: Insulet Reports First Quarter 2016 Financial Results 24
Feb 25, 2016: Insulet Reports Fourth Quarter and Full Year 2015 Financial Results 25
Corporate Communications 27
May 30, 2017: Insulet Appoints Bret Christensen as Chief Commercial Officer 27
Oct 19, 2016: Insulet Announces Board and Management Changes 28
Feb 09, 2016: Insulet Appoints David A. Lemoine to Board of Directors 29
Other Significant Developments 30
Sep 06, 2016: Insulet to Establish Highly-Automated Manufacturing Operation in the United States 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31
List of Tables
Insulet Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Insulet Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Insulet Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Insulet Corp, Medical Devices Deals, 2011 to YTD 2017 9
Insulet Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Insulet Raises Private Placement of Senior Notes for USD345 Million 11
Insulet Prices Public Offering of 2% Notes Due 2019 for USD175 Million 12
Sinoxa Pharma Acquires Patent Rights To Omnipod Patch-Pump Technology From Insulet 13
Insulet Acquires Neighborhood Diabetes 14
Insulet Corp, Key Competitors 16
Insulet Corp, Key Employees 17
Insulet Corp, Subsidiaries 18List of Figures
Insulet Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Insulet Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Insulet Corp, Medical Devices Deals, 2011 to YTD 2017 9
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter